CASH FLOW INFORMATION

6 Months Ended

Jun. 30, 2024

CASH FLOW INFORMATION

CASH FLOW INFORMATION

3 – CASH FLOW INFORMATION

For the six months ended June 30, 2024, the Company had non-cash investing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expenses consisting of $702 for the Purchase of vessels and ballast water treatment systems, including deposits, $373 for the Purchase of other fixed assets, $39 for Vessels held for sale and $75 for the Net proceeds from sale of vessels. For the six months ended June 30, 2024, the Company had non-cash financing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expense consisting of $1,230 for Cash dividends payable.

For the six months ended June 30, 2023, the Company had non-cash investing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expenses consisting of $749 for the Purchase of vessels and ballast water treatment systems, including deposits, and $301 for the Purchase of other fixed assets. For the six months ended June 30, 2023, the Company had non-cash financing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expense consisting of $853 for Cash dividends payable.

During the six months ended June 30, 2024 and 2023, cash paid for interest was $7,071 and $6,641, respectively, which was offset by $588 and $3,443 received as result of the interest rate cap agreements, respectively.

During the six months ended June 30, 2024 and 2023, any cash paid for income taxes was insignificant.

All stock options exercised during the six months ended June 30, 2024 and 2023 were cashless. Refer to Note 13 — Stock-Based Compensation for further information.

On May 23, 2024, the Company granted 38,122 restricted stock units to certain members of the Board of Directors. The aggregate fair value of these restricted stock units was $825.

On February 21, 2024, the Company granted 168,411 restricted stock units and 99,065 performance-based restricted stock units to certain individuals. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $3,060 and $2,143, respectively.

On June 16, 2023, the Company granted 3,917 restricted stock units and 3,917 performance-based restricted stock units to an individual. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $56 and $64, respectively.

On May 16, 2023, the Company granted 43,729 restricted stock units to certain members of the Board of Directors. The aggregate fair value of these restricted stock units was $600.

On April 14, 2023, the Company granted 75,920 restricted stock units and 75,920 performance-based restricted stock units to certain individuals. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $1,237 and $1,451, respectively.

On April 3, 2023, the Company granted 1,630 restricted stock units to an individual. The aggregate fair value of these restricted stock units was $25.

On March 10, 2023, the Company granted 2,948 restricted stock units to an individual. The aggregate fair value of these restricted stock units was $50.

On February 21, 2023, the Company granted 68,758 restricted stock units to certain individuals. The aggregate fair value of these restricted stock units was $1,250.

Refer to Note 13 — Stock-Based Compensation for further information regarding the aforementioned grants.

Supplemental Condensed Consolidated Cash Flow information related to leases is as follows:

	For the Six Months Ended
	June 30,
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	1,226	$	1,152